Exposure to uncontrolled fire, not in building or structure

VWXY20_EXPOS_UNCONT_FIRE_NOT_BUILD_STRUCTURE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — X01 Cause of death: ICD-10 — X01 2 out of 7 registries used, show all original rules.	78
4. Check minimum number of events None	78
5. Include endpoints None	78
6. Filter based on genotype QC (FinnGen only)	78

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 5
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: X0

NAME	VWXY20_EXPOS_UNCONT_FIRE_NOT_BUILD_STRUCTURE
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	X01
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	X01
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Exposure to uncontrolled fire, not in building or structure based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	78	34	44
Unadjusted period prevalence (%)	0.02	0.01	0.02
Median age at first event (years)	51.26	50.03	52.20

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
73: Matched controls
729

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

X01

ICD-10 Finland

Exposure to uncontrolled fire, not in building or structure

+∞

99.5

T20.2

ICD-10 Finland

Burn of second degree of head and neck

+∞

16.2

QCD20

NOMESCO Finland

Excision of burn of upper limb and coverage

170.4

14.0

ZZA00

NOMESCO Finland

Split skin graft

21.2

12.4

S14

ICPC

Burn/scald

19.4

12.1

T23.2

ICD-10 Finland

Burn of second degree of wrist and hand

42.5

11.7

QDD00

NOMESCO Finland

Dressing of major burn of lower limb

+∞

10.7

QBD20

NOMESCO Finland

Excision of burn of trunk and coverage

114.2

9.7

T31.0

ICD-10 Finland

Burns involving less than 10% of body surface

+∞

9.6

QCD00

NOMESCO Finland

Dressing of major burn of upper limb

101.3

8.6

QDD20

NOMESCO Finland

Excision of burn of lower limb and coverage

50.6

7.9

X09

ICD-10 Finland

Exposure to unspecified smoke, fire and flames

88.7

7.6

T29.3

ICD-10 Finland

Burns of multiple regions, at least one burn of third degree mentioned

+∞

7.4

SPAT1148

SPAT

Treatment of chronic ulcer or burn

5.7

6.9

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

7.9

6.8

T31.1

ICD-10 Finland

Burns involving 10-19% of body surface

+∞

6.3

QBD00

NOMESCO Finland

Dressing of major burn of trunk

+∞

6.3

T20.0

ICD-10 Finland

Burn of unspecified degree of head and neck

+∞

6.3

X58

ICD-10 Finland

Exposure to other specified factors

4.9

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4.95

5.83

2.7

1.8

—

(3044640) Blood type and Crossmatch panel - Blood

190

2.95

5.19

3.6

2.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

3.50

4.94

3.3

1.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

294

2.79

4.57

5.2

3.8

—

(3027801) Oxygen [Partial pressure] in Arterial blood

3.37

4.51

12.3

5.6

11.10

12.00

kpa

0.37

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3.37

4.51

12.4

5.6

5.25

4.91

kpa

0.56

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3.41

4.42

7.0

2.9

—

(3016502) Oxygen saturation in Arterial blood

3.36

4.30

12.9

5.9

94.58

95.80

0.40

(3002032) Base excess in Venous blood by calculation

3.47

4.13

3.4

5.9

1.38

1.60

mmol/l

0.09

(3000991) Gas panel - Venous blood

3.40

3.82

15.4

6.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

144

2.61

3.81

3.0

2.1

—

(3025941) Bacteria identified in Stool by Culture

4.10

3.79

1.3

1.2

—

(3012544) pH of Venous blood

3.21

3.69

3.5

5.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3.97

3.63

1.9

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3.15

3.58

14.2

6.2

118.69

126.65

g/l

0.82

(3042936) Bacteria identified in Isolate by Culture

2.86

3.47

4.7

1.9

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

10.55

3.02

1.6

1.8

—

(3023368) Bacteria identified in Blood by Culture

137

2.35

2.91

6.3

4.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

3.05

2.88

5.1

2.4

9.25

9.52

g/l

0.12

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

4.28

2.87

1.7

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

8.79

2.79

1.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

243

2.10

2.60

9.4

4.7

35.04

36.67

g/l

0.81

231

(3033658) Prothrombin time (PT) actual/Normal

153

2.17

2.51

9.9

3.5

88.93

93.16

0.52

153

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

4.41

2.42

1.1

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

4.16

2.31

1.1

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

4.16

2.31

1.1

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

5.85

2.24

1.2

1.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

5.85

2.24

2.4

2.6

6.78

8.03

kpa

—

(3028707) Methadone [Presence] in Urine by Screen method

3.94

2.20

5.0

2.2

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2.95

2.20

20.8

6.8

93.69

93.78

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

451

2.12

2.18

5.4

3.0

56.73

40.77

u/l

1.18

422

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

5.26

2.10

1.2

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

4.24

2.08

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

4.77

1.97

1.0

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2.77

1.87

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

4.37

1.85

3.6

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

4.37

1.85

1.2

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

3.24

1.84

1.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

233

1.81

1.75

4.9

3.4

23.11

37.25

ng/l

0.66

147

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

4.03

1.74

1.4

2.0

—

(3032080) INR in Blood by Coagulation assay

227

1.79

1.66

19.2

6.4

1.33

1.13

inr

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2.40

1.54

3.0

6.4

23.08

24.46

mmol/l

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2.54

1.51

23.6

6.0

—

(3016879) Cocaine [Presence] in Urine

2.54

1.51

4.1

1.8

—

(3000764) Benzodiazepines [Presence] in Urine

2.47

1.49

4.1

1.7

—

(3028300) Cannabinoids [Presence] in Urine

2.47

1.49

4.1

1.7

—

(3027944) Amphetamines [Presence] in Urine

2.47

1.49

4.1

1.7

—

(3027008) Opiates [Presence] in Urine

2.47

1.49

4.1

1.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.25

1.46

1.6

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.94

1.45

1.6

1.7

—

(3003694) ABO and Rh group [Type] in Blood

183

1.73

1.39

1.4

1.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2.16

1.35

1.5

1.8

338.09

377.85

nmol/l

0.39

(1001926) Buprenorphine [Presence] in Urine by Screen method

2.50

1.33

4.5

2.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

152

1.73

1.28

1.4

1.3

0.63

1.03

u/ml

0.52

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.08

1.24

1.7

1.5

—

(3026008) Bacteria identified in Urine by Culture

147

1.69

1.17

3.4

2.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2.46

1.15

1.3

2.5

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1.80

1.14

11.6

4.0

0.79

0.82

mmol/l

0.92

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.01

1.14

1.8

1.7

—

(3022313) Gas panel - Capillary blood

2.38

1.13

2.4

3.1

—

(3049717) Cytology report of Urine Cyto stain

2.36

1.05

2.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.10

1.03

7.9

6.5

24.04

24.29

mmol/l

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

0.00

0.99

0.0

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

211

0.59

0.97

3.4

4.1

21.94

22.03

—

(40758558) Short blood count panel - Blood

147

1.59

0.93

11.5

6.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

219

1.52

0.93

1.8

1.7

86.69

97.14

pmol/l

0.69

104

(3002582) Erythrocytes [#/volume] in Urine

174

1.55

0.92

4.1

3.0

47.03

44.33

e6/l

0.03

134

(3000330) Specific gravity of Urine by Test strip

2.16

0.91

6.3

3.6

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

175

1.54

0.89

3.3

2.1

281.79

203.94

u/l

0.37

167

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

203

1.50

0.87

3.8

3.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1.64

0.83

3.1

2.7

1.01

0.89

e6/l

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.80

0.0

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.80

0.0

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.80

0.0

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.80

0.0

1.6

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.80

0.0

1.4

—

(3045414) Leukocytes [Presence] in Urine

2.25

0.77

1.4

1.8

—

(4010399)

1.87

0.75

1.1

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.66

0.73

2.1

1.8

—

(3018095) Leukocytes [#/volume] in Urine

201

1.44

0.72

4.6

3.5

220.24

23.01

e6/l

0.57

141

(3019060) Gas panel - Arterial blood

1.78

0.72

2.1

4.5

—

(3020891) Body temperature

1.98

0.72

2.8

4.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

121

1.52

0.70

1.7

1.8

—

(3011288) Drugs identified in Urine by Screen method

1.91

0.69

4.8

2.0

—

(3022621) pH of Urine by Test strip

1.65

0.67

4.9

2.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

142

1.45

0.62

1.9

2.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.61

0.0

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.61

0.0

1.8

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.59

0.0

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.59

0.0

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.59

0.0

1.4

—

(3000494) Fungus identified in Specimen by Culture

1.59

0.55

1.9

1.4

—

(3002256) Pathology report gross observation

1.51

0.55

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.54

0.53

2.3

2.6

—

(3000850) Epithelial cells [#/volume] in Urine

111

1.44

0.51

3.1

2.5

3.99

3.34

e6/l

0.18

100

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

654

1.48

0.48

30.5

11.5

24.00

22.16

mg/l

0.19

484

(3030467) Casts [#/volume] in Urine by Automated count

158

1.36

0.48

3.5

3.0

0.16

0.19

e6/l

0.12

117

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1.44

0.47

4.0

2.8

2.38

3.29

e6/l

—

(3015736) pH of Urine

234

1.31

0.47

4.8

3.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

141

1.36

0.45

10.6

4.3

—

(3026782) Osmolality of Urine

106

1.39

0.43

4.3

2.7

568.50

620.66

mosm/kgh2o

0.38

(3037467) Urinalysis macro (dipstick) panel - Urine

424

1.27

0.42

5.6

3.8

—

(42870588) Differential panel, method unspecified - Blood

199

1.30

0.42

10.5

5.9

—

(3022145) Colonoscopy Study observation

1.47

0.41

1.1

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

0.00

0.40

0.0

1.7

—

198.89

—

(36304419) Bacteria [Presence] in Urine

154

1.31

0.39

3.1

2.8

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1.50

0.37

5.7

4.0

4.44

4.56

pmol/l

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1.46

0.36

5.2

4.5

1.23

mmol/l

—

(3021589) Normoblasts [#/volume] in Blood

270

1.25

0.36

20.2

9.1

0.00

e9/l

0.50

217

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.43

0.36

1.2

1.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

184

1.27

0.36

6.4

2.9

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.67

0.35

7.3

7.1

—

(40761536) Microorganisms panel - Urine sediment

1.36

0.34

3.5

3.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1.27

0.30

5.9

4.8

43.69

10.18

ug/l

—

(1761868) Lipid panel - Serum or Plasma

254

0.81

0.29

3.4

2.5

—

(40768804) Tissue Pathology biopsy report

242

0.82

0.27

1.8

—

(3019150) Specific gravity of Urine by Refractometry

144

1.23

0.24

6.6

3.4

1.02

kg/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.75

0.24

2.0

1.6

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.21

0.0

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

0.21

0.0

4.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

154

0.81

0.21

4.3

3.4

2440.15

1101.94

ng/l

0.36

129

(3025130) Human papilloma virus identified in Specimen

0.00

0.21

0.0

2.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

61.50

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

0.00

0.21

0.0

1.7

—

10.88

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.27

0.21

2.5

2.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

185

1.18

0.21

3.0

4.0

2.77

12.37

mg/mmol

2.26

116

(40768800) Prostate Pathology biopsy report

0.00

0.20

0.0

1.2

—

(40768793) Breast Pathology biopsy report

0.00

0.20

0.0

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

141

0.82

0.18

2.8

3.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1.16

0.18

3.3

2.1

15.96

13.05

nmol/l

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

0.77

0.16

1.7

1.8

—

(40768797) Stomach Pathology biopsy report

1.23

0.16

1.7

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

248

1.14

0.15

6.4

3.2

—

(3013512) EKG study

171

1.15

0.14

6.3

3.6

—

(3044889) 12 lead EKG panel

440

0.90

0.12

4.6

3.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

613

1.14

0.12

26.8

13.0

38.28

41.04

1.70

486

(3029937) Albumin [Presence] in Urine by Test strip

164

1.13

0.11

4.8

3.1

0.00

estimate

—

(36660697) Celiac disease serology panel - Serum

1.14

0.09

1.2

—

(40761511) CBC panel - Blood by Automated count

698

1.19

0.07

25.9

11.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.04

0.07

1.8

2.3

—

(3035350) Ketones [Presence] in Urine by Test strip

307

1.07

0.06

5.9

3.3

0.00

estimate

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

439

1.06

0.04

3.0

3.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

308

0.96

0.02

9.1

4.7

0.00

estimate

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

134

0.96

0.00

1.6

1.5

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

606

1.03

0.00

26.2

10.8

89.76

85.59

ml/min/173m2

0.73

480

(3009261) Glucose [Presence] in Urine by Test strip

316

1.02

0.00

5.9

3.3

0.00

estimate

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.2

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

0.0

2.5

—

965.83

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

0.0

1.0

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

5.7

—

166.78

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.0

1.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.0

2.5

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.2

—

9.56

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.00

0.0

1.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.0

1.5

—

123.50

—

(3019225) pH of Specimen

0.90

0.00

5.6

4.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.0

2.3

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1.00

0.00

1.0

1.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.0

2.3

—

(4146454)

0.00

0.0

2.3

—

(3025577) Chromium [Mass/volume] in Blood

0.00

0.0

2.2

—

2.36

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

26.28

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.00

0.00

1.3

2.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.0

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.0

2.3

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.00

0.0

1.6

—

12.80

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

0.0

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.0

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.0

2.3

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.0

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.0

2.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

0.0

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.0

2.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

0.00

0.0

2.0

—

52.00

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.0

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

0.89

0.00

1.9

2.0

—

(3034426) Prothrombin time (PT)

0.00

0.0

1.2

—

(3026470) Cobalt [Mass/volume] in Blood

0.00

0.0

2.2

—

3.70

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: VWXY20_EXPOS_UNCONT_FIRE_NOT_BUILD_STRUCTURE – Exposure to uncontrolled fire, not in building or structure

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Exposure to uncontrolled fire, not in building or structure

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Exposure to uncontrolled fire, not in building or structure (VWXY20_EXPOS_UNCONT_FIRE_NOT_BUILD_STRUCTURE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints